Abstract
It is reported on the symptomatology, diagnostics and therapy in a 54-year-old patient with a micromolecular plasmocytoma of kappa-type. Here particularly the impressionable improvement of the clinical picture after an intermitting impact therapy with melphalan (alkeran) - prednisolone in a period of treatment of approximately 2 years is emphasized.
MeSH terms
-
Bence Jones Protein / urine
-
Humans
-
Immunoglobulin kappa-Chains / urine
-
Lumbar Vertebrae / diagnostic imaging
-
Male
-
Melphalan / therapeutic use
-
Middle Aged
-
Neoplasm Metastasis
-
Osteolysis / etiology
-
Plasmacytoma* / blood
-
Plasmacytoma* / diagnosis
-
Plasmacytoma* / drug therapy
-
Prednisolone / therapeutic use
-
Radiography
Substances
-
Immunoglobulin kappa-Chains
-
Bence Jones Protein
-
Prednisolone
-
Melphalan